Purchasers and the Company), with each Forward Purchase Unit having a purchase price of $20.00 and consisting of one share of the Class A common stock (the “Forward Purchase Shares”), and one-third of one warrant bearing the legend set forth in Exhibit B hereto (the “Forward Purchase Warrants” and together with the shares of Class A common stock issuable upon the exercise thereof, the Forward Purchase Units and the Forward Purchase Shares, the “Forward Purchase Securities”) in one or more private placement transactions to occur in such amounts and at such time or times as the Forward Purchasers determine, but no later than simultaneously with the closing of the Company’s initial Business Combination;
WHEREAS, on July 21, 2020, the Company entered into that certain Director Forward Purchase Agreement (the “Director Forward Purchase Agreement”) with certain of its directors or director nominees (the “Director Forward Purchasers”) pursuant to which each of the Director Forward Purchasers will purchase Forward Purchase Units, in an aggregate amount of $6,000,000, in one or more private placement transactions to occur in such amounts and at such time or times as the Director Forward Purchasers determine, but no later than simultaneously with the closing of the Company’s initial Business Combination;
WHEREAS, on July 21, 2020, the Company entered into that certain Sponsor Warrant Purchase Agreement, with Pershing Square TH Sponsor, LLC, a Delaware limited liability company (the “Sponsor”) pursuant to which the Sponsor will purchase a warrant (the “Sponsor Warrant”) in connection with the Company’s Offering (as defined below) and simultaneously with the closing of the Offering, for an aggregate purchase price of $65,000,000, which will be exercisable for 5.95% of the common shares of the post-Business Combination (as defined below) entity on a fully diluted basis, with an exercise price of $24.00 per share of the post-Business Combination entity, pursuant to that certain Sponsor Warrant Agreement, dated July 21, 2020, between the Company and the Warrant Agent;
WHEREAS, on July 21, 2020, the Company entered into that certain Director Warrant Purchase Agreement, with certain directors or director nominees of the Company, pursuant to which each such director may purchase a warrant (each, a “Director Warrant”) for a purchase price of up to $812,500, simultaneously with the closing of the Company’s Offering (as defined below). Each Director Warrant will have an exercise price of $24.00 per share and will be exercisable for that number of shares of the post-Business Combination entity as provided in that certain Director Warrant Agreement, dated July 21, 2020, between the Company and the Warrant Agent;
WHEREAS, on July 21, 2020, the Company entered into that certain Letter Agreement (the “Letter Agreement”), with Sponsor, the Company’s directors or director nominees and the Forward Purchasers, pursuant to which, among other things, the Forward Purchase Securities held by the Forward Purchasers are subject to certain transfer restrictions;
WHEREAS, on July 21, 2020, the Company entered into that certain Registration Rights Agreement (the “Registration Rights Agreement”), with Sponsor, the Company’s directors or director nominees and the Forward Purchasers, providing for the registration for resale of certain securities held by the parties thereto;
WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, No. 333-239342 (as amended from time to time, the “Registration Statement”) and will file a prospectus (the “Prospectus”) for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), for the Units, the shares of Class A common stock included in the Units, the Redeemable Warrants, and the contingent right to receive the Distributable Tontine Redeemable Warrants;
WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Redeemable Warrants and the Forward Purchase Warrants (collectively, the “Warrants”);
WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent and the holders of the Warrants; and
-2-